EV/EBITDA
-0.56
+0.04+6.67%
2 min ago
Summary
- As of February 7, 2025, LYEL EV/EBITDA is -0.56, with a rise of +0.04 (+6.67%) during the most recent trading day.
- Over the past year, LYEL EV/EBITDA has increased by +1.05 (+65.22%).
- LYEL EV/EBITDA is now -1.82% below its all-time high of -0.55.
Performance
LYEL EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
LYEL EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +6.7% | -5.9% | -4.2% |
| 1 m1 month | +20.0% | -19.1% | -14.1% |
| 3 m3 months | +63.4% | -63.3% | -54.5% |
| 6 m6 months | +59.1% | -60.4% | -59.3% |
| ytdytd | +11.1% | -10.4% | -7.5% |
| 1 y1 year | +65.2% | -69.5% | -67.4% |
| 5 y5 years | - | - | - |
LYEL EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -1.8% | -0.71 | +21.1% | |
| 3 m | 3-month | -0.55 | -1.8% | -1.85 | +69.7% |
| 6 m | 6-month | -0.55 | -1.8% | -1.85 | +69.7% |
| 1 y | 1-year | -0.55 | -1.8% | -3.18 | +82.4% |
| 3 y | 3-year | -0.55 | -1.8% | -10.59 | +94.7% |
| 5 y | 5-year | -0.55 | -1.8% | -20.30 | +97.2% |
| alltime | all time | -0.55 | -1.8% | -20.30 | +97.2% |
Lyell Immunopharma EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.56(-11.1%) |
| 2024 | -0.63(-65.2%) |
| Date | Value |
|---|---|
| 2023 | -1.81(-61.2%) |
| 2022 | -4.66(-43.3%) |
| 2021 | -8.22 |
FAQ
- What is Lyell Immunopharma EV/EBITDA?
- What is the all time high EV/EBITDA for Lyell Immunopharma?
- What is LYEL EV/EBITDA year-to-date change?
- What is Lyell Immunopharma EV/EBITDA year-on-year change?
What is Lyell Immunopharma EV/EBITDA?
The current EV/EBITDA of LYEL is -0.56
What is the all time high EV/EBITDA for Lyell Immunopharma?
Lyell Immunopharma all-time high EV/EBITDA is -0.55
What is LYEL EV/EBITDA year-to-date change?
Lyell Immunopharma EV/EBITDA has changed by +0.07 (+11.11%) since the beginning of the year
What is Lyell Immunopharma EV/EBITDA year-on-year change?
Over the past year, LYEL EV/EBITDA has changed by +1.05 (+65.22%)